Company Filing History:
Years Active: 2009-2017
Title: Dirk Finsinger: Innovator in Pharmaceutical Chemistry
Introduction
Dirk Finsinger is a prominent inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work focuses on developing innovative compounds that have the potential to treat various medical conditions.
Latest Patents
One of Finsinger's latest patents is for substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors. This invention relates to tetrahydro-tetrazolo[1,5-a]pyrazine compounds that are useful for inhibiting the retinoid-related orphan receptor gamma (ROR-gamma). These compounds can aid in the prevention and treatment of medical conditions such as rheumatoid arthritis, multiple sclerosis, psoriasis, ulcerative colitis, asthma, autoimmune hepatitis, and both type 1 and type 2 diabetes. Another notable patent involves substituted tetrahydroquinolines, which can be employed for the treatment of tumors.
Career Highlights
Finsinger has worked with notable companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Throughout his career, Finsinger has collaborated with esteemed colleagues such as Frank Zenke and Christiane Amendt. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Dirk Finsinger is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of various medical conditions. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.